IP Library Granted Patent US 9,242,950
Granted Patent B2
US 9,242,950 · App. 13/538,189 · Granted Jan 26, 2016

Method for preparing a fatty acid derivative

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,242,950
App. No.
13/538,189
Granted
Jan 26, 2016
Kind
B2
Abstract

A method for manufacturing a fatty acid derivative represented by formula (I) is provided: wherein Z 1 is wherein R3 is a protecting group for a hydroxy group; which includes the step of reacting a compound of formula (II): wherein Z 2 is the same as Z 1 except for when Z 1 is Z 2 is with a co-oxidizer under the presence of an azaadamantane-N-oxyl derivative.

Claims (26)

1. A method for manufacturing a fatty acid derivative represented by formula (I):

wherein X 1 is

wherein R1 is a protecting group for hydroxy group;

Y 1 is

wherein R2 is a protecting group for hydroxy group;

Z 1 is

wherein R3 is a protecting group for hydroxy group, provided that at least one of X 1 , Y 1 and Z 1 is

A is —CH 3 , —CH 2 OH, —COCH 2 OH, —COOH or a salt, ether, ester or amide thereof;

B is a single bond, —CH 2 —, —CH 2 —CH 2 —, —CH═CH— or —C≡C—, —CH 2 —CH 2 —CH 2 —, —CH═CH—CH 2 —, —CH 2 —CH═CH—, —C≡C—CH 2 — or —CH 2 —C≡C—;

Ra is bivalent saturated or unsaturated lower-medium aliphatic hydrocarbon group, which is unsubstituted or substituted by halogen atom, lower alkyl, lower alkoxy, oxo, aryl or heterocyclic group, provided that one or more carbon atoms of the aliphatic hydrocarbon group may optionally be replaced with oxygen, nitrogen or sulfur atom; and

Rb is hydrogen atom; saturated or unsaturated lower-medium aliphatic hydrocarbon group which is unsubstituted or substituted by a halogen, oxo, hydroxy, lower alkoxy, lower alkanoyloxy, cyclo(lower)alkyl, cyclo(lower)alkyloxy, aryl, aryloxy, heterocyclic or heterocyclic oxy;

cyclo(lower)alkyl; cyclo(lower)alkyloxy; aryl; aryloxy; heterocyclic; or heterocyclic oxy, which comprises the step of, reacting a compound of formula (II):

wherein, X 2 is the same as X 1 except for when X 1 is

X 2 is

Y 2 is the same as Y 1 except for when Y 1 is

Y 2 is

Z 2 is the same as Z 1 except for when Z 1 is

Z 2 is

provided that at least one of X 2 , Y 2 and Z 2 is

and, A, B, Ra and Rb are the same as above;

with a co-oxidizer under the presence of an azaadamantane-N-oxyl compound.

2. The method of claim 1 , wherein A is —COOH or a salt, ester or amide thereof.

3. The method of claim 1 , wherein the azaadamantane-N-oxyl compound is 2-azaadamantane-N-oxyl.

4. The method of claim 1 , wherein the azaadamantane-N-oxyl compound is 1-methyl-2-azaadamantane-N-oxyl.

5. The method of claim 1 , wherein the azaadamantane-N-oxyl compound is 2-hydroxy-2-azaadamantane.

6. The method of claim 1 , wherein the azaadamantane-N-oxyl compound is 2-hydroxy-1-methyl-2-azaadamantane.

Assignments (9)
SECURITY INTEREST Recorded Oct 28, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: GOLDMAN SACHS BANK USA, AS ADMINISTRATIVE AGENT
Reel/Frame 072700/0001 →
RELEASE OF SECURITY INTEREST Recorded Aug 14, 2025
From: ACQUIOM AGENCY SERVICES LLC
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
Reel/Frame 072324/0740 →
SECURITY INTEREST Recorded Aug 1, 2025
From: STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: COMPUTERSHARE TRUST COMPANY, NATIONAL ASSOCIATION
Reel/Frame 071913/0691 →
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 060434, FRAME 0536 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; VTESSE LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; SUCAMPO PHARMA AMERICAS LLC
Reel/Frame 065601/0347 →
RELEASE OF SECURITY INTERESTS IN PATENTS AT REEL 060389/FRAME 0913 Recorded Nov 15, 2023
From: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
To: OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); MALLINCKRODT LLC; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
Reel/Frame 065583/0465 →
SECURITY INTEREST Recorded Nov 15, 2023
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; OCERA THERAPEUTICS LLC; SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC
To: ACQUIOM AGENCY SERVICES LLC
Reel/Frame 065595/0376 →
NOTICE OF GRANT OF SECURITY INTEREST IN INTELLECTUAL PROPERTY Recorded Jun 22, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 060434/0536 →
SECURITY INTEREST Recorded Jun 17, 2022
From: MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; SPECGX LLC; OCERA THERAPEUTICS, INC.; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC; MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 060389/0913 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 28, 2012
From: MATSUKAWA, TATSUYA; YAMAMOTO, NORIYUKI; UENO, RYUJI; KOTAJIMA, HIROYUKI; FUKUYA, SHUNSUKE; HANDA, MICHIHARU; SAKATA, KATSUYA
To: R-TECH UENO, LTD.; SUCAMPO AG
Reel/Frame 028861/0982 →